Skip to main content
. 2018 Aug 14;2018(8):CD012327. doi: 10.1002/14651858.CD012327.pub2
Summary for the risk of any hypertensive disorders of pregnancy (not defined) in women with GDM
Probably ineffective or harmful interventions
  • Moderate‐quality evidence suggested that insulin possibly increased the risk of hypertensive disorders of pregnancy (not defined) compared with oral therapy.


No conclusions possible: low‐ to very low‐quality evidence, or insufficient evidence to comment on the effectiveness, more evidence needed
  • Moderate‐quality evidence showed no clear difference for metformin versus glibenclamide.

  • Very low‐quality evidence showed no clear difference for glibenclamide versus placebo